Elevance Health, Inc.
ELV Healthcare Healthcare Plans
Elevance Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $199.1 billion, up 12.5% from fiscal 2024.
- Revenue
- +1.42%
- EPS
- +17.9%
- Free cash flow
- +29.0%
- Total debt
- −3.65%
Quarter to September 2026, against a year earlier
Follow ELV
Alert me
Elevance Health, Inc. (ELV) P/E ratio
As of 6 November 2026, Elevance Health, Inc. (ELV) trades at a P/E ratio of 18.2×. Over the past ten years it has ranged from 9.5× (March 2020) to 23.4× (July 2021); the current reading is higher than 68% of that period. That is below the Healthcare Plans industry median of 22.5× and below the Healthcare sector median of 24.5×.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 14.0× | (3.12%) |
| FY2024 | 14.4× | (24.28%) |
| FY2023 | 19.0× | (6.09%) |
| FY2022 | 20.3× | 8.03% |
| FY2021 | 18.8× | 4.59% |
| FY2020 | 17.9× | 9.46% |
| FY2019 | 16.4× | (11.44%) |
| FY2018 | 18.5× | 17.52% |
| FY2017 | 15.7× | 1.19% |
| FY2016 | 15.6× | 4.06% |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Sep 2026 | 16.6× | (3.53%) |
| Jun 2026 | 17.2× | 38.03% |
| Mar 2026 | 12.5× | (10.77%) |
| Dec 2025 | 14.0× | 5.64% |
| 43 more quarters | Free account |
Against its own ten years
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| MOH Molina Healthcare, Inc compare | n/m |
| CVS CVS Health Corporation compare | 9.6× |
| OSCR Oscar Health, Inc. compare | 11.0× |
| CI Cigna Group compare | 12.9× |
| ELV Elevance Health, Inc. | 18.2× |
| UNH UnitedHealth Group Incorporated compare | 22.5× |
| CNC Centene Corporation compare | 23.5× |
| PGNY Progyny, Inc. compare | 30.1× |
| HUM Humana Inc. compare | 41.9× |
| Healthcare Plans industry median | 22.5× |
| Healthcare sector median | 24.5× |
| Market median | 17.8× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)
More on ELV
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement